Cyprus tourist arrivals dipped 76.9% reaching 100,791 in October 2020 from 436,509 in the same month of 2019, due to pandemic travel restrictions, official data showed Tuesday. For the first 10 months
A requirement for workers exempted from the lockdown travel ban in Limassol and Paphos to carry a negative coronavirus test was postponed for a day until Thursday following chaotic scenes at testing
Cyprus scientists are encouraged by the latest discovery of a COVID-19 vaccine having an efficiency rate of 94.5%, the highest so far in immunity against the virus. Pharmaceutical Moderna pioneering in messenger
Cyprus health authorities announced 107 new cases of SARS-CoV-2 on Monday, the third day with a steady drop in new infections following the 207 on Friday. However, this number is expected to
Cyprus Justice Minister Emily Yiolitis criticised protests against COVID-19 measures after a Limassol demonstration against the lockdown turned ugly. Yiolitis told state broadcaster CyBC on Monday that demonstrations in Limassol are prohibited
Despite scientists believing tougher restrictions will reduce COVID infections by the end of November, curbs on gatherings and social distancing will make this Christmas a stoic affair. Epidemiologist Dr Michael Voniatis told
Passenger traffic at European airports has collapsed by 81% along with air connectivity causing wide disruption due to the pandemic, Airports Council International said Monday. It said passenger movement was being decimated
A free rapid testing program, focussing on COVID hotspots Paphos and Limassol was launched on Monday to help health authorities identify the extent to which the virus has spread in the community.
Following a public outcry over the way police handled roadblocks on highways into Limassol and Paphos, causing long queues, Justice Minister Emily Yiolitis on Monday ordered police to only conduct random checks.
Βy Hussein Sayed, Chief Market Strategist at FXTM Last week was a game-changer in world markets. Monday’s announcement from Pfizer and BioNTech of robust results from their late-stage trial for the Covid-19
